Professional Documents
Culture Documents
Coffee Heart and Blood Vessels
Coffee Heart and Blood Vessels
Coffee Heart and Blood Vessels
Publishers
Coffee and Health Information Bureau
Copyright
© november 2007, Coffee and Health Information Bureau, Amsterdam
Availability
The brochure ‘Coffee, heart and blood vessels’ can be ordered free of charge
from Coffee and Health Information Bureau. You can also register here for the
digital newsletter. This free Dutch newsletter is aimed at health care profes-
sionals and keeps you informed about the most recent scientific information
concerning coffee and health and appears four to five times a year.
Is it advisable to drink coffee when you have a ‘heart condition’? Does drinking
coffee have any influence on the occurrence and development of cardiovascular
disease? People used to think so. But what is the current advice? Heavy coffee
drinkers are quite often also heavy smokers. For instance, in one of the first
studies in this field the relationship between drinking coffee and cardiovascular
disease could be wholly attributed to the fact that coffee drinkers had been
smoking more (Katan, 1994). More recent studies, have adjusted for ‘other’
factors that could influence the results.
This does not mean there are no further questions about coffee and heart
conditions and the risk factors for cardiovascular disease (blood pressure and
cholesterol). Coffee is consumed by 8 out of 10 Dutch people every day and
total annual consumption of coffee per head of the population amounts to 144
litres (VNKT, 2006). Research on the effects of coffee and heart health continues
to be an important field of scientific investigation.
In the last few decades there has been significant scientific research into the
relationship between coffee and health, including drinking coffee and risk
factors for cardiovascular disease. This brochure is aimed at health care profes-
sionals and provides a summary of the results of innumerable scientific studies.
The questions were formulated in collaboration with the Dutch Working Group
for Cardiology Dieticians. You can read more about the influence of coffee on
heart conditions in chapter 1. Chapter 2 describes the relationship between
coffee and cholesterol and chapter 3 gives more information about coffee and
blood pressure.
The Coffee and Health Information Bureau (Voorlichtingsbureau voor Koffie en
Gezondheid) sought assistance from three scientists who carry out research in
this field. Dr. Marianne Gelijnse (nutritional epidemiologist, Human Nutrition
Department, Wageningen University) and Dr. Cuno Uiterwaal (MD, clinical
epidemiologist, Julius Centre, Utrecht University Medical Centre) assisted in
If you have any questions or comments about this brochure, please let us know.
Literature
Katan MB, Koffie, cholesterol en coronaire hartziekten. Hart Bulletin, 1994; 25:119-123.
4 |
1 Coffee and cardiovascular disease
Analysis of several extensive cohort studies (see shaded text on page 35) does
not show a relationship between coffee consumption and the risk of cardiovas-
cular disease (Grobbee, 1990; Woodward, 1999; Willett, 1996; Lopez-Garcia,
2006; Frost-Andersen, 2006). Furthermore, there is no evidence of a link
between coffee consumption and disease prognosis after myocardial infarction
(Mukamal, 2004).
Type 2 diabetes is a strong risk factor for cardiovascular disease. The inverse
relationship between coffee consumption and type 2 diabetes was first de-
scribed in 2002 (Van Dam, 2002). This Dutch epidemiological study among
more than 17,000 men and women showed that people who drank seven
or more cups of coffee a day were 50% less likely to develop type 2 diabetes
than people who drank two cups of coffee or less. A 2005 meta-analysis also
indicated a link between coffee consumption and a substantially lower risk of
developing type 2 diabetes (Van Dam, 2005). More recent studies confirm this
inverse relationship. Moreover these studies show that this effect occurs with
decaffeinated coffee as well. Furthermore, a recent Finnish study investigating
almost 4,000 people with type 2 diabetes indicated a reduced risk of cardiovas-
cular mortality in the case of those who drank three or more cups of coffee a
day (Bidel, 2006).
Little is known about coffee consumption in relation to the risk of heart failure.
A Swedish study examined risk factors for heart failure in a long-term follow-
up among almost 7,500 men. Risk factors for the occurrence of heart failure
included increasing age, family history of myocardial infarction, diabetes, chest
pain, smoking, high coffee consumption, excessive alcohol, high BMI and
hypertension (Wilhelmsen, 2001). Epidemiological data from the Framingham
study indicate that hypertension has the highest impact on heart failure and
is responsible for about 39% of heart failure in men and 59% in women. After
adjustment for age and other factors, hypertension increases the risk of heart
6 |
failure by a factor of 2 in men and a factor 3 in women. Diabetes increases
the risk of heart failure by a factor of 2 to 8, more so in women than in men
(Kannel, 2000). This study did not investigate the relationship between coffee
and heart failure. However, coffee is associated with a decreased risk of diabetes
and a lower risk of cardiovascular mortality in the case of people with diabetes
(see shaded text on page 6).
3 Can you still drink coffee if you suffer from heart failure?
A 2006 study investigated the effect of caffeine on the stamina of patients with
heart failure (Notarius, 2006). Ten patients were infused intravenously with 4
mg of caffeine per kg bodyweight or a placebo. With caffeine, patients were
able to exercise longer at peak effort. However, this study is much too limited to
be able to derive any recommendation from it.
A large Danish prospective cohort study among nearly 48,000 people investi-
gated the relationship between daily caffeine consumption from various foods
and the incidence of arrhythmia. The study could not find any relationship bet-
ween arrhythmia and caffeine, not even in the case of high concentrations (997
mg/day, equivalent to approximately 10 cups of coffee a day (Frost, 2005)).
An eight year long prospective cohort study among nearly 129,000 Americans
over a period of 8 years did not show any relationship between coffee con-
sumption and cardiac arrhythmia mortality (Klatsky, 1993). Intervention studies
with caffeine in amounts of up to 450 mg/day (comparable to 5 small cups of
coffee a day) showed no relationship with the nature or frequency of cardiac
arrhythmia, either in healthy people or in heart patients (Myers, 1991; Nawrot,
2003). Conversely, caffeine restriction was found not to have any effect on pa-
tients with ventricular tachyarrhythmia (fast and abnormal heart rate) (Newby,
1996).
8 |
6 Can coffee influence homocysteine levels of blood?
Various large cohort studies show that there is no relationship between cof-
fee consumption and cardiovascular diseases (see question 1). Little research
has been undertaken into the effect of caffeine consumption on patients with
angina pectoris. A Dutch study (Riksen, 2006) tested the effect of caffeine on
so-called preconditioning in an experimental model involving healthy volun-
teers (see shaded text on page 11). In an experimental model, healthy patients
received a single intravenous injection of caffeine (4 mg/kg body weight) in
the forearm. Caffeine was found to have an adverse impact on the protective
effect of preconditioning. However, the researcher states that the results of this
experimental study cannot be extrapolated to daily coffee consumption. It is not
possible to give advice on this until further research among patients has estab-
lished whether a high plasma caffeine concentration at the moment a heart
attack takes place will worsen the course of events (Riksen, 2007).
Normally, people drink their coffee in the course of the day, so that the caffeine
is absorbed via the gastrointestinal tract over a longer period of time and the
physiological effect would not be the same as that seen when a single dose of
caffeine is injected into the blood stream. Furthermore, the effect of coffee is not
always the same as that of caffeine (see question 8).
10 |
Angina pectoris and preconditioning
A heart attack will not be as serious when people have just had an angina pec-
toris attack. In the case of angina pectoris so-called preconditioning occurs. For
a moment, the heart muscle receives insufficient oxygen. This makes the heart
muscle more tolerant of a longer period of oxygen shortage, such as occurs in
the case of myocardial infarction. Adenosine, which occurs naturally in the body,
plays an important part in preconditioning. Caffeine is a so-called adenosine-
antagonist and can block the effect of adenosine. The preconditioning
mechanism does not reduce the occurrence of cardiovascular disease, but once
a myocardial infarction has occurred it can limit its seriousness.
Caffeine is without doubt the most examined substance in coffee. The effects of
pure caffeine are regularly translated directly to coffee, but this does not always
prove justified. Pure caffeine (in tablet form) for example is found to be capable
of increasing the blood pressure, while this hardly occurs if at all in the case of
the same quantity of caffeine via coffee (Noordzij, 2005; see chapter 3.)
Coffee contains much more than just caffeine. For instance it contains potas-
sium and magnesium, which may be capable of counteracting the blood-
pressure-increasing effect of caffeine. Coffee is also a good source of anti-
oxidants (polyphenols such as chlorogenic acids).
12 |
9 Can people with cardiovascular disease consume coffee
normally?
Most studies show that there are no indications that moderate consumption
of coffee (approximately 4 - 5 cups a day) increases the risk of cardiovascular
disease related to healthy people. A number of studies have examined whether
caffeine consumption or abstinence from caffeine consumption affect the blood
pressure of people with hypertension (see chapter 3) or in the case of patients
with cardiac arrhythmia. To date there are no indications for advising people
with cardiac arrhythmia against drinking coffee (see question 5). Nonetheless,
individuals concerned with the possible effects of coffee in relation to cardiovas-
cular disease, should seek the advice of their medical practitioner.
Bidel S e.a., Coffee consumption and risk of total and cardiovascular mortality among patients with
diabetes type 2. Diabetologia, 2006; 49(11):2618-2626.
Christensen B e.a., Abstention from fi ltered coffee reduces the concentrations of plasma homocysteine
and serum cholesterol-a randomized controlled trial. Am J Clin Nutr, 2001; 74(3):302-307.
Esposito F e.a., Moderate coffee consumption increases plasma glutathione but not homocysteine in
healthy subjects. Aliment Pharmacol Ther, 2003; 17:595-601.
Frost L and Vestergaard P, Caffeine and risk of atrial fi brillation or fl utter: the Danish Diet, Cancer, and
Health Study. Am J Clin Nutr, 2005; 81(3):578-582.
Frost Andersen L e.a., Consumption of coffee is associated with reduced risk of death attributed to
inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr, 2006;
83:1039-1046.
Grobbee DE, e.a., Coffee, caffeine, and cardiovascular disease in men. New Eng J Med, 1990;
323:1026-1032.
Grubben MJ e.a., Unfi ltered coffee increases plasma homocysteine concentrations in healthy volun-
teers: a randomized trial. Am J Clin Nutr, 2000; 71:448-484.
Hammar N e.a., Association of boiled and fi ltered coffee with incidence of fi rst nonfatal myocardial
infarction: the SHEEP and the VHEEP study. J Intern Med, 2003; 253(6):653-659.
Higdon JV and Frei B., Coffee and Health: A Review of Recent Human Research. Crit Rev Food Sci Nutr,
2006; 46:101-123.
Kannel WB, Incidence and epidemiology of heart failure. Heart Fail Rev 2000; 5(2):167-173.
Klatsky AL, e.a., Coffee, tea, and mortality. Ann Epid, 1993; 3:375-381.
Lopez-Garcia E e.a., Coffee consumption and coronary heart disease in man and women: a prospective
cohort study. Circulation, 2006; 113(17):2045-2053.
Mukamal KJ e.a., Caffeinated coffee consumption and mortality after acute myocardial infarction.
AmHeart J, 2004; 147:999-1004.
Myers MG, Caffeine and cardiac arrhythmias. Ann Intern Med, 1991; 114(2):147-150.
Nawrot P e.a., Effects of caffeine on human health. Food Addit Contam, 2003; 20(1):1-30.
Newby DE e.a., Caffeine restriction has no role in the management of patients with symptomatic
idiopathic ventricular premature beats. Heart, 1996; 76(4):355-357.
14 |
Noordzij M e.a., Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of
randomized controlled trials. J Hypert, 2005; 23:921-928.
Notarius CF e.a., Caffeine prolongs exercise duration in heart failure. J Card Fail, 2006; 12(3):220-226.
Olthof MR e.a., Consumption of high doses of chlorogenic acid, present in coffee, or of black tea incre-
ases plasma total homocysteine concentrations in humans. Am J Clin Nutr, 2001; 73:532-538.
Refsum H e.a., The Hordaland Homocysteine Study: a community-based study of homocysteine, its
determinants, and associations with disease. J Nutr, 2006; 136(6 suppl):1731S-1740S.
Riksen NP e.a., Caffeine Prevents Protection in Two Human Models of Ischemic Preconditioning.
J AmColl Cardiol, 2006; 48:700-707.
Urgert R e.a., Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in
healthy volunteers. Am J Clin Nutr, 2000; 72:1107-1110.
Van Dam R and Feskens E, Coffee consumption and risk of type 2 diabetes mellitus. The Lancet, 2002;
360(9344):1477-1478.
Van Dam R and Hu F, Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA, 2005;
294:97-104.
Verhoef P and Katan MB, A healthy lifestyle lowers homocysteine, but should we care? Editorial Am
J Clin Nutr, 2004; 79:713-714.
Wilhelmsen L e.a., Heart failure in the general population of men-morbidity, risk factors and prognosis.
J Intern Med, 2001; 249(3):253-261.
Willett WC e.a., Coffee consumption and coronary heart disease in women. A ten-year follow-up.
JAMA, 1996; 275(6):458-462.
Woodward M and Tunstall-Pedoe H, Coffee and tea consumption in the Scottish Heart Health Study
follow up: confl icting relations with coronary risk factors, coronary disease, and all cause mortality.
J Epid Comm Health, 1999; 53:481-487.
That depends on the brewing method used for making coffee. Unfiltered coffee
can increase the serum cholesterol level, while filtered coffee does not have this
effect (Boekschoten, 2003, 2006; Urgert, 1996a; Urgert, 1996b). The increase
in cholesterol is attributable to the diterpenes cafestol and kahweol, two fat-
soluble substances that are naturally present in coffee oil. The effect of cafestol,
in particular, on serum cholesterol levels has been demonstrated (Urgert, 1997).
Only in the case of certain coffee brewing methods the diterpenes do permeate
the brewed coffee. Scandinavian-type boiled coffee, French press (Cafetière
or plunger) coffee, Greek coffee and Turkish coffee for instance contain these
substances in higher concentrations. In the case of filtered coffee and coffee
made with coffee pods, the most common methods of brewing coffee in
the Netherlands, cafestol and kahweol are retained by the filter. These coffees
therefore have no cholesterol-raising effect (Ahola, 1991; Dusseldorp, 1991;
Boekschoten, 2006). Instant coffee and vending-machine coffee based on liquid
coffee concentrate also contain hardly any diterpenes and have a neglible effect
on serum lipids (Urgert, 1997; Sara Lee/DE, 1998).
The diterpenes, cafestol and kahweol naturally present in coffee oil increase se-
rum cholesterol levels (see question 1 in this chapter). Whether these diterpenes
permeate the coffee brew and to what extent depends on the brewing method.
Boiled coffee, coffee that is prepared by boiling ground coffee in water and pou-
ring the brew without filtering it, contains the diterpenes, cafestol and kahweol
in higher concentrations. The amounts of diterpenes in boiled coffee vary from
3.0 to 10.9 mg of cafestol and 3.9 to 10.7 mg of kahweol per cup (Urgert,
1995; Boekschoten, 2006). Consuming large amounts of boiled coffee will in-
crease the serum cholesterol level. French press coffee, Greek coffee and Turkish
coffee also contain comparable amounts of cafestol and kahweol (Urgert, 1995).
In the case of filtered coffee and coffee made with coffee pods, the diterpenes
are retained in the paper filter. Both these coffees contain an average of 0.1 mg
cafestol and 0.1 mg kahweol per cup (Urgert, 1995; Boekschoten 2006). The ef-
fect of this on the serum cholesterol content is therefore negligible. Instant cof-
fee and vending-machine coffee based on liquid coffee concentrate also contain
negligible amounts of cafestol and kahweol. These substances are virtually fully
removed during the production process (Sara Lee/DE, 1998).
In the case of espresso coffee and coffee from vending machines in which the
coffee is freshly brewed, these types of coffee may contain cafestol and kahweol.
The ultimate quantity and the effect on serum cholesterol content depends on
a combination of factors, such as the type of machine, the type and quantity of
coffee, the type of filter used and the number of cups consumed daily.
18 |
3 How substantial is the effect of cafestol on the cholesterol
content?
Based on intervention studies (see shaded text on page 35) an estimate has
been made that, daily intake of 10 mg of cafestol for a period of 4 weeks, will
result in an increase of 0.13 mmol/l in the total cholesterol level of the blood
(Weusten van der Wouw, 1994). However, in the case of long-term consump-
tion the increase in serum cholesterol level becomes less, which may point to
partial adaptation by the body to the effects of diterpenes (Urgert, 1996b).
Consumption of a litre per day of very strong coffee brewed in a Cafetière
(plunger or French press) (38 mg of cafestol and 33 mg of kahweol) for a period
of six months resulted after 12 weeks in a maximum increase in serum choles-
terol of 0.52 mmol/l. Thereafter the cholesterol level declined again and after
six months the total increase was still 0.30 mmol/l compared with the starting
values. Shorter-term studies can result in overestimation of the effect (Urgert,
1997).
How much kahweol contributes to raising serum cholesterol is not fully un-
derstood, since no studies have been carried out with pure kahweol. What
is known, however, is that a mixture of cafestol and kahweol has a slightly
stronger effect than cafestol on its own (Urgert, 1997). Moreover the effect
of the diterpenes is reversible. After cessation of consumption of cafestol and
kahweol serum cholesterol levels return to their starting values (Urgert, 1996a).
The table on page 20 shows the various brewing methods, the cafestol and kah-
weol levels of the associated brews and the estimated serum cholesterol increase
in the case of consumption of 5 cups of coffee a day (after Urgert, 1996a).
20 |
4 Do regular and decaffeinated coffee have different effects on
the blood cholesterol level?
This depends once again entirely on the coffee brewing method (see questions
1 and 2). Filtered coffee does not have a cholesterol-raising effect (see question
1). However, if a lot of unfiltered coffee is drunk, switching from unfiltered to
filtered coffee results in a clear fall in serum cholesterol levels. This is the case in
Scandinavian countries, where traditionally a large amount of boiled coffee was
previously consumed (Pietinen, 1996).
Intervention studies have also revealed that the effect of diterpenes is reversible.
If consumption is ceased, the serum cholesterol values return to their starting
levels (Urgert, 1996a).
22 |
Spread of cholesterol measurements
People with a raised cholesterol level may choose to continue to drink coffee
with negligible amounts of cafestol, such as filtered coffee and coffee made with
coffee pods; or up to 2-3 cups of espresso coffee consumed over the course of
the day (Urgert, 1996a).
24 |
Coffee, heart and blood vessels | 25
Literature
Ahola I e.a., The hypercholesterolaemic factor in boiled coffee is retained by a paper fi lter. J Intern
Med, 1991; 230:293-297.
Bak AA and Grobbee DE. The effect of serum cholesterol levels of coffee brewed by fi ltering or boiling.
N Eng J Med, 1989; 321:1432-1437.
Boekschoten MV e.a., Reproducibility of the serum lipid response to coffee oil in healthy volunteers.
Nutr J, 2003; 2(1):8.
Cavin C e.a., Cafestol and kahweol, two coffee specifi c diterpenes with antiocarcionogenic activity.
Food Chem Toxicol, 2002; 40(8):1155-1163.
Devaraj S e.a., The role of dietary supplementation with plant sterols and stanols in the prevention of
cardiovascular disease. Nutr Rev, 2006; 64:348-352.
Dusseldorp M van e.a., Effect of decaffeinated versus regular coffee on serum lipoproteins. A 12 week
double blind trial. Am J Epidem, 1990; 132(1):33-40.
Dusseldorp M van e.a., Cholesterol-raising factor from boiled coffee does not pass a paper fi lter. Arthe-
rios Thromb, 1991; 11:586-593.
Huber W e.a., Potential chemoprospective effect of the coffee components kahweol and cafestol pal-
mirates via modifi cation of hepatic N-acetyltransferase and glutathione-S-transferase activities. Environ
Mol Mutagen, 2004; 44(4):265-276.
Kim JY e.a., Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macro-
phages. FEBS Letters, 2004; 569:321-326.
Lee KJ e.a., Hepatoprotective and antioxidant effects of coffee diterpenes kahweol and cafestol on
carbon tetrachloride-induced liver damage in mice. Food. Chem. Toxicol., 2007: doi:10.1016/j.
fct.2007.05.010.
Pietinen P e.a., Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk.
Prev Med, 1996; 25:243-250.
26 |
Ricketts, ML e.a., The Cholesterol-Raising Factor from Coffee Beans, Cafestol, as an Agonist Ligand for
the Farnesoid and Pragnane X Receptors. Mol Endocrinol, 2007; 21:1603-1616.
Smith SJ e.a., Biological variability in concentrations of serum lipids: sources of variation among results
from published studies and composite predicted values. Clin Chem, 1993; 39(6):1012-1022.
Tavani A, Coffee and cancer: a review of epidemiological studies, 1990-1999. Eur J Canc Prev, 2000;
9(4):241-256.
Urgert R e.a., Levels of the Cholesterol-Elevating Diterpenes Cafestol and Kahweol in Various Coffee
Brews. J Agric Food Chem, 1995; 43:2167-2172.
Urgert R and Katan MB, The cholesterol-raising factor from coffee beans. J R Soc Med, 1996a;
89(11):618-623.
Urgert R e.a., Comparison of effect of cafetiere and fi ltered coffee on serum concentrations of liver
aminotransferases and lipids: six month randomised controlled trial. Br Med J, 1996b; 313:1362-1366.
Urgert R and Katan MB, The cholesterol-raising factor from coffee beans. Annu Rev Nutr, 1997; 17:305-
324.
Weusten van der Wouw PME e.a., Identity of the cholesterol-raising factor from boiled coffee and its
effects on liver function enzymes. J Lip Res, 1994; 35:721-733.
Regular consumption of coffee has either very little or no effect on blood pres-
sure in the case of people with normal blood pressure (Myers, 1991; Stamler,
1997; Jee, 1999; Geleijnse, 2004; Noordzij, 2005; Winkelmayer, 2005; Uiter-
waal, 2007).
There is, however, a difference between the short-term effect and the effect in
the longer term. Shortly after consumption, drinking coffee slightly increases
blood pressure, the effect being comparable with the effect on blood pressure
of holding a conversation (Nurminen, 1999). This type of acute effect results
from the caffeine, and the blood pressure falls again within a few hours to its
starting level. In addition, tolerance appears to occur in terms of the effect of
caffeine (Casiglia, 1992; Jee, 1997). Studies relating to a longer term effect indi-
cate that coffee has negligible if any impact on blood pressure (Geleijnse, 2004;
Noordzij, 2005; Winkelmayer, 2005; Uiterwaal, 2007).
Various studies show that coffee has no specific effect on the risk of hyperten-
sion (Klag, 2002; Geleijnse 2004; Winkelmayer, 2005, Uiterwaal, 2007). In the
Dutch cohort study carried out by Uiterwaal et al on almost 3,000 men and al-
most 3,400 women without hypertension, the long-term effects of drinking cof-
fee on the risk of hypertension (systolic pressure >140 mmHg) were examined.
Even after correction for other factors, the group that never drank coffee was
found to have a lower risk of hypertension than people who consumed small
amounts of coffee (1 - 3 cups a day) (Uiterwaal, 2007). However, the group of
non-coffee drinkers was small and it is possible that not drinking coffee is linked
with a different and more healthy lifestyle which could not be entirely corrected
for. A striking result was that women who drank a lot of coffee (>6 cups a day)
30 |
had a lower risk of hypertension. A comparable result was also found in the case
of the Nurses’ Health Study of more than 155,000 women without hyperten-
sion, who were monitored over a period of 12 years (Winkelmayer, 2005).
Consumption of more than 6 cups of coffee a day was found to have a slightly
protective effect on the risk of hypertension. Cola on the other hand was found
to be related to an increased risk of hypertension.
Research in people with hypertension shows that withholding coffee has no ef-
fect on the blood pressure of hypertensive patients (MacDonald, 1991; Nurmi-
nen, 1998). Blood pressure was also not further increased as a result of drinking
coffee in the case of people with moderate hypertension.
Known risk factors that play a major role in the case of hypertension are obesity,
physical inactivity, high salt intake and low potassium intake (Geleijnse, 2004).
There are no indications for advising against coffee consumption for individuals
with hypertension. At this moment most research suggests that regular intake of
caffeinated coffee does not increase the risk of hypertension.
Sensitive to caffeine?
Caffeine has a mildly stimulating effect on the central nervous system. This ex-
presses itself in the form of heightened alertness and concentration and a redu-
ced feeling of fatigue. In the case of people who are sensitive to caffeine, it can
also cause restlessness, trembling or increased time taken to fall asleep. Caffeine
sensitive individuals are advised to limit the quantity of caffeine to an amount
at which the individual experiences minimal effects from caffeine. These people
may also choose for example to drink decaffeinated coffee. Women who are
pregnant or breast-feeding are advised to limit their daily intake of caffeine to a
maximum of 300 mg. In some countries e.g. the UK, the upper recommended
limit is 200mg. Tea, cola, energy drinks, drinking chocolate and some painkillers
are also sources of caffeine intake (see table on page 8).
32 |
Coffee, heart and blood vessels | 33
Literature
Casiglia E e.a., Haemodynamic effects of coffee and purifi ed caffeine in normal volunteers: a placebo-
controlled clinical study. J Hum Hypertens, 1992; 6(2):95-99.
Geleijnse JM e.a., Impact of dietary and lifestyle factors on the prevalence of hypertension in Western
populations. Eur J Pub Health, 2004;14:235-239.
Jee SH e.a., The effect of coffee on blood pressure, a meta analyses of controlled clinical trials. Can
J Cardiol 1997; 13(Suppl B):36B.
Jee SH e.a., The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clini-
cal trials. Hypertension, 1999; 33(2):647-52.
Klag MJ e.a., Coffee intake and the risk of hypertension: the Johns Hopkins precursors study. Arch Intern
Med, 2002; 162(6):657-62.
MacDonald TM e.a., Caffeine restriction: effect on mild hypertension. Br Med J, 1991; 303:1235-1238.
Myers MG en Reeves RA, The effect of caffeine on daytime ambulatory blood pressure. Am J Hypert,
1991; 4:427-431.
Noordzij M e.a., Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of
randomized controlled trials. J Hypert, 2005; 23:921-928.
Nurminen ML e.a., Dietary factors in the pathogenesis and treatment of hypertension. Ann Med, 1998;
30(2):143-150.
Nurminen ML e.a., Coffee, caffeine and blood pressure: a critical review: Euro J Clin Nutr, 1999;
53:831-839.
Stamler J e.a., Relation of Relation of body mass and alcohol, nutrient, fi ber, and caffeine intakes to
blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention
Trial. Am J Clin Nut, 1997; 65(suppl):338-65.
Uiterwaal C e.a., Coffee intake and incidence of hypertension, Am J Clin Nutr, 2007; 85:718-723.
Winkelmayer WC e.a., Habitual Caffeine Intake and the Risk of Hypertension in Women. JAMA, 2005;
294:2330-2335.
34 |
Study of coffee and health
Every type of research has its own evidential value and limitations. Most of the
studies reported in this brochure can be differentiated into:
2. Intervention study: In the case of this type the effect of the substance to
be investigated on a group of people is measured and compared with a
control group, which is not given the substance. Intervention studies in
the area of coffee research are usually relatively short and the group size is
limited.
3. Cohort study (prospective): In this brochure in the case of this type of study
large groups of people have been monitored (prospectively) over a longer
period. In this context at the start of the study differences in coffee con-
sumption between people who have and have not developed a (medical)
condition during the study are examined. The pattern of coffee consump-
tion of the participants has therefore not been influenced by the condition.